Interim Guidelines for the Clinical Management of Hypertension in Jamaica

Objectives

Provide interim, evidence-based clinical guidance to improve hypertension control at individual and population levels, pending a comprehensive revision by the Ministry of Health and Wellness.[1]Reduce hypertension-related morbidity and mortality, including damage to the heart, brain, kidneys and blood vessels, through effective detection, early diagnosis and appropriate management.[2]

• Strengthen primary-care practice to identify hypertension before substantial target-organ damage occurs and to support timely treatment.[2][3]
• Apply the Seventh Report of the Joint National Committee classification while recognising that cardiovascular risk rises progressively below diagnostic thresholds.[4]
• Promote lifestyle modification for people with blood pressure below 120/80 mmHg and for those with prehypertension.[4][5]
• Assess people with prehypertension for diabetes or prediabetes, dyslipidaemia and obesity.[5][6]
• Reduce blood pressure among diagnosed patients through lifestyle measures, stepped pharmacological treatment and specialist referral where hypertension remains uncontrolled.[6]
• Address hypertension in clinical circumstances requiring tailored care, including diabetes, cardiovascular disease, pregnancy, older age, stroke, aortic disease, atrial fibrillation and elective major surgery.[7][8]

The material focuses principally on clinical hypertension management rather than a population-wide cardiovascular strategy; it does not specify a wider strategic framework, measurable document-level targets, formal areas of action, or a time-bound national implementation plan beyond the stated aim of improved hypertension control.[1][2][3]

Implementation

Deliver hypertension care principally through primary-care physicians and other health practitioners, supported by updated guidance from the Ministry of Health and Wellness and the Association of Consultant Physicians of Jamaica.[1][2]Use regular screening, standardised blood-pressure assessment, risk evaluation, lifestyle support, medicines, referral pathways, home monitoring and telehealth to provide continuous care.[2][9][10][11]

• Measure office blood pressure in both arms and repeat measurements when an inter-arm difference exceeds 15 mmHg; use the arm with the persistently higher reading.[9]
• Take a second clinic reading when the first is at least 140/90 mmHg, take a third where the second differs substantially, and record the lower of the final two readings.[9]
• Confirm hypertension over further visits rather than from a single encounter unless hypertensive urgency, emergency, marked elevation or relevant target-organ damage warrants earlier classification.[4][9][12]
• Offer ambulatory blood-pressure monitoring when clinic blood pressure is 140/90 to 160/100 mmHg, and use home monitoring where ambulatory monitoring is unsuitable, not tolerated or less practical.[9][10]
• Review patients with readings of at least 160/100 mmHg within two weeks where target-organ damage is absent, and assess markedly elevated readings for damage to relevant organs.[9][12]
• Undertake baseline assessment using urinalysis, albuminuria or proteinuria testing, blood count, renal function, electrolytes, lipid profile, calcium and estimated glomerular filtration rate, alongside diabetes screening.[12]
• Investigate young patients, people with resistant hypertension and those with suggestive symptoms for secondary causes, and arrange specialist referral where indicated.[12]
• Promote weight reduction, the Dietary Approaches to Stop Hypertension eating plan, reduced sodium intake, regular aerobic activity and moderation of alcohol consumption.[6]
• Initiate treatment with an appropriate calcium channel blocker, angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, or thiazide or thiazide-like diuretic; consider low-dose single-pill combinations and intensify to two- and then three-drug regimens if control is not achieved.[6]
• Refer patients whose blood pressure remains uncontrolled on three medicines to a hypertension specialist, cardiologist or internist.[6]
• Arrange referral according to clinical urgency, including non-urgent review within one to two months, urgent review within one week for marked elevation without symptoms or signs, and same-day emergency care for acute target-organ damage.[10]
• Maintain continuity between referral services and Health Centres or primary-care physicians by sharing relevant clinical findings, laboratory results, diagnoses and treatment information.[10]
• Train patients under medical supervision to select validated automated home devices, use correct cuff sizes and measurement techniques, interpret variability, and retain readings in device memory or written logs.[13]
• Take at least two home readings one minute apart, twice daily, before medication in the morning and before supper in the evening, and use average waking-hour readings to assess response to treatment.[13]
• Use telehealth, including telephone, video, messaging and connected devices, for suitable patients with available records; obtain consent, explain the limits of remote care, and direct unstable or seriously unwell patients to face-to-face or urgent care.[13][11]
• Protect telehealth information through secure platforms, secure internet connections, virtual private networks, strong passwords and encryption, and convert to face-to-face care where examination, confidentiality, safeguarding or technical circumstances require it.[11]
• Document telehealth encounters to the same standard as face-to-face care, including clinical information, advice, the use of telehealth and any authorised recording.[14][15]

Operational governance is limited in the supplied material. It does not specify a detailed governance structure, stakeholder accountability framework, implementation timetable, programme budget, financing allocation, or formal monitoring and evaluation system; however, it calls for health-insurance coverage of telehealth consultations at in-office rates.[1][13][11]

Monitoring & Evaluation

Monitoring centres on repeated blood-pressure measurement, confirmation outside the clinic where appropriate, clinical assessment for target-organ damage, ongoing review of treatment response, and documentation of in-person and telehealth care. Formal programme-level evaluation, reporting schedules, surveillance arrangements, indicators and accountability mechanisms are not specified, apart from national survey findings and clinical record requirements.[2][4][10][14]

• Use regular screening to detect asymptomatic hypertension before substantial end-organ damage occurs. The Jamaica Health and Lifestyle Survey 2016-2017 estimated hypertension prevalence at approximately 34% among Jamaicans aged 15 years and over using a 140/90 mmHg threshold, with 40% of affected people unaware of their condition.[2]
• Track treatment and control gaps highlighted by the survey: 70% of diagnosed people were taking medication, but only 30% of people receiving medication had controlled blood pressure. Using a 130/80 mmHg threshold, estimated prevalence was 58%.[2]
• Confirm diagnosis through repeated office readings rather than a single encounter, except in hypertensive urgency or emergency. Use ambulatory blood-pressure monitoring for clinic readings of 140/90 to 160/100 mmHg, or home monitoring where ambulatory monitoring is unsuitable or not tolerated.[4][9]
• Standardise clinic measurement by measuring both arms, repeating readings where the inter-arm difference exceeds 15 mmHg, and using the higher-reading arm if the difference persists. Take a second reading after an initial measurement of at least 140/90 mmHg, take a third when needed, and record the lower of the last two readings.[9]
• Repeat measurements on two further occasions within one month for readings from 140/90 mmHg to below 160/100 mmHg without target-organ damage. Review readings of at least 160/100 mmHg within two weeks where damage is absent, and assess target-organ damage when interpreting markedly elevated readings.[9]
• Undertake baseline and follow-up clinical assessment using urinalysis, albuminuria or proteinuria testing, blood count, renal function, electrolytes, lipid profile, calcium and estimated glomerular filtration rate. Screen initially and annually for diabetes with fasting and two-hour postprandial blood glucose.[12]
• Use clinically indicated chest X-ray, twelve-lead electrocardiography and abdominal ultrasonography to identify cardiac, renal or secondary causes and target-organ damage. Evaluate younger people, those with resistant hypertension, and patients with suggestive symptoms for secondary hypertension, with additional testing selected according to clinical assessment.[12][5]
• Monitor home blood pressure through at least two readings one minute apart, twice daily, ideally over seven days, and review stored device readings or written logs during clinic visits. Use average usual waking-hour readings to assess treatment response, with targets below 135/85 mmHg for adults under 80 years and below 145/85 mmHg for adults aged 80 years or over.[10][13]
• Use home monitoring to investigate suspected white-coat or masked hypertension and support medicine titration alongside telehealth counselling or other clinical interventions. Investigate markedly elevated blood pressure without symptoms for target-organ damage, repeat clinic measurement within seven days when damage is absent, and consider immediate treatment when damage is identified.[10]
• Maintain continuity and clinical accountability through referral communications and exchange of laboratory results, diagnoses and current treatment information between referral services, Health Centres and primary-care physicians.[10]
• Document telehealth histories, clinical observations or examination findings, decision-making information, advice, and the use of telehealth in the patient record. Apply the same documentation standards as for face-to-face care, obtain consent before recording consultations, and retain any authorised recording in the record.[14][15]
• Monitor blood pressure closely during intravenous treatment for acute intracranial haemorrhage.[7]

Costing & Financing

Costing, programme budgets, funding allocations, funding gaps, resource-mobilisation measures and economic assumptions are not specified. The only explicit financing direction is that health insurance providers should reimburse or cover telehealth consultations at the same rate as in-office consultations.[1][2][13][11]

• Provide reimbursement or insurance coverage for telehealth consultations at in-office rates.[13][11]
• Resource home monitoring with validated automated blood-pressure devices, preferably with memory storage, and calibration or comparison with a validated clinical device every six months. No associated cost or funding source is specified.[13]
• Support telehealth delivery with secure platforms, internet access, virtual private networks, password protection and encryption, while recognising that no budget, financing mechanism or economic assumption is specified for these requirements.[11]